Stocks of Connecticut’s largest publicly traded companies have taken the same hit as the broader market in recent weeks, but that can’t overshadow the good run many in-state businesses had in recent years.In fact, the average annual stock return for publicly traded Connecticut companies was 13.98 percent over a five-year period ending March 31, according […]
Stocks of Connecticut's largest publicly traded companies have taken the same hit as the broader market in recent weeks, but that can't overshadow the good run many in-state businesses had in recent years.
In fact, the average annual stock return for publicly traded Connecticut companies was 13.98 percent over a five-year period ending March 31, according to a recent analysis by New York data research firm SmartAsset.
Cheshire drug maker Alexion Pharmaceuticals Inc. had the best performing stock over the last five years averaging a 48.18 percent annual return, according to the analysis, which identified stocks that offer the best return for the least amount of risk. Six out of 10 companies were based in Fairfield County.
Four Greater Hartford companies were in the top 10. Aside from Alexion, Bloomfield insurer Cigna was ranked No. 4 in Connecticut while Hartford insurer Aetna was No. 8 and Manchester manufacturer Lydall was No. 10. Only companies headquartered in Connecticut were ranked in the state's top 10.
SmartAsset examined the stock performance of each company from Dec. 30, 2009 to March 31, 2015 to determine which had the best growth rate in price and paid the most dividends while providing the least amount of investor risk. All companies publicly traded on the New York Stock Exchange, Nasdaq and AMEX were examined.
Alexion, which is best known for its blood and immune system drug Soliris, scored a 71.5 in SmartAsset's stock performance index, which is a combination of the stock's average annual return and volatility. That is 7 percent higher than Stamford-based Charter Communications, which ranked No. 2 on the list.
Stamford's Gartner Inc. and Norwalk-based The Priceline Group rounded out the top five, ranking No. 3 and 5 respectively.
— Brad Kane
